Related Experiment Video
Updated: Oct 16, 2025
08:45
Characterizing RNA Modifications in Single Neurons Using Mass Spectrometry
Published on: April 21, 2022
2.5K
Effect, Mechanism, and Applications of Coding/Non-coding RNA m6A Modification in Tumor Microenvironment
Chaohua Si1,2, Chen Chen2, Yaxin Guo3,4
1Department of Colorectal Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Frontiers in Cell and Developmental Biology
|October 18, 2021
Summary
N6-methyladenosine RNA modifications (m6A RNA modifications) are crucial in the tumor microenvironment (TME), influencing cancer progression. Understanding this link offers new therapeutic strategies for cancer treatment.
Area of Science:
- Oncology
- Molecular Biology
- Immunology
Background:
- The tumor microenvironment (TME) comprises cells and molecules supporting tumor growth and metastasis.
- N6-methyladenosine (m6A) RNA modifications are prevalent epigenetic marks influencing gene expression.
- m6A RNA modifications play a significant role in various cancer processes.
Purpose of the Study:
- To review the multifaceted role of m6A RNA modifications within the TME.
- To explore the potential of m6A RNA modifications as biomarkers and therapeutic targets in oncology.
- To highlight the implications of TME-m6A interactions for future cancer therapy.
Main Methods:
- Literature review of studies investigating m6A RNA modifications in the TME.
- Analysis of the impact of m6A RNA modifications on immune cells, fibroblasts, and tumor cells.
- Synthesis of current research on m6A-targeted cancer therapies.
Main Results:
- m6A RNA modifications dynamically regulate cellular components within the TME.
- Aberrant m6A patterns are associated with tumor development, progression, and immune evasion.
- m6A regulators are emerging as promising targets for novel cancer treatments.
Conclusions:
- m6A RNA modifications are integral to TME functions and cancer biology.
- Targeting m6A pathways holds significant promise for developing effective cancer therapies.
- Further research into the TME-m6A interplay will pave the way for innovative cancer treatment strategies.
Related Concept Videos
01:22MicroRNAs
3.2K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.2K
02:39lncRNA - Long Non-coding RNAs
9.0K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.0K
01:53RNA Stability
34.2K
Intact DNA strands can be found in fossils, while scientists sometimes struggle to keep RNA intact under laboratory conditions. The structural variations between RNA and DNA underlie the differences in their stability and longevity. Because DNA is double-stranded, it is inherently more stable. The single-stranded structure of RNA is less stable but also more flexible and can form weak internal bonds. Additionally, most RNAs in the cell are relatively short, while DNA can be up to 250 million...
34.2K
01:20Types of RNA
6.9K
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in regulating gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA Performs Diverse...
RNA Performs Diverse...
6.9K
03:03mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
02:51mRNA Stability and Gene Expression
5.9K
The structure and stability of mRNA molecules regulates gene expression, as mRNAs are a key step in the pathway from gene to protein. In eukaryotes, the half-life of mRNA varies from a few minutes up to several days. mRNA stability is essential in growth and development. The absence of the proteins regulating its stability, such as tristetraprolin in mice, can cause systemic issues, including bone marrow overgrowth, inflammation, and autoimmunity.
Cis-acting Elements involved in mRNA stability
Cis-acting Elements involved in mRNA stability
5.9K